Skip to main content

Part of Cancer staging guidance sheets

Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)

Current Chapter

Current chapter – Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)


Introduction

This is the data sheet for TNM 8th edition staging of the malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)

For more detailed information regarding TNM staging, please see pages 142-146 of the UICC TNM 8 book or visit the Wiley and UICC website.


Stage groupings

Clinical stage

Stage Group

T stage

N stage

M stage

Stage 0

pTis

N0

M0

Stage IA

pT1a

N0

M0

Stage IB

pT1b

N0

M0

pT2a

N0

M0

Stage IIA

pT2b

N0

M0

 

pT3a

N0

M0

Stage IIB

pT3b

N0

M0

 

pT4a

N0

M0

Stage IIC

pT4b

N0

M0

Stage III

Any pT

N1, N2, N3

M0

Stage IV

Any pT

Any N

M1

Pathological stage*

Stage Group

T stage

N stage

M stage

Stage 0

pTis

N0

M0

Stage I

pT1

N0

M0

Stage IA

pT1a

N0

M0

pT1b

N0

M0

Stage IB

pT2a

N0

M0

Stage IIA

pT2b

N0

M0

 

pT3a

N0

M0

Stage IIB

pT3b

N0

M0

 

pT4a

N0

M0

Stage IIC

pT4b

N0

M0

Stage III

Any pT

N1, N2, N3

M0

Stage IIIA

pT1a, T1b, T2a

N1a, N2a

M0

Stage IIIB

pT1a, T1b, T2a

N1b, N1c, N2b

M0

 

pT2b-T3a

N1, N2a, N2b

M0

Stage IIIC

pT1a, T1b, T2a, T2b, T3a

N2c, N3

M0

 

pT3b, T4a

N1, N2, N3

M0

 

pT4b

N1, N2

M0

Stage IIID

pT4b

N3

M0

Stage IV

Any pT

Any N

M1

Note: * If lymph node(s) are identified with no apparent primary the stage is as below

Stage IIIB

T0

N1b, N1c

M0

Stage IIIC

T0

N2b, N2c, N3b, N3c

M0


TNM clinical classification

T - primary tumour

The extent of the tumour is classified after excision, see pT.

N - regional lymph nodes

N value Description

NX

Regional lymph nodes cannot be assessed

N0

No regional lymph node metastasis

N1

Metastasis in one regional lymph node or intralymphatic regional metastasis without nodal metastases

N1a - Only microscopic metastasis (clinically occult)

N1b - Macroscopic metastasis (clinically apparent)

N1c - Satellite or in‐transit metastasis without regional nodal metastasis

N2

Metastasis in two or three regional lymph nodes or intralymphatic regional metastasis with lymph node metastases

N2a - Only microscopic nodal metastasis

N2b - Macroscopic nodal metastasis

N2c - Satellite or in‐transit metastasis with only one regional nodal metastasis

N3

Metastasis in four or more regional lymph nodes, or matted metastatic regional lymph nodes, or satellite(s) or in‐transit metastasis with metastasis in two or more regional lymph node(s)

N3a - Only microscopic nodal metastasis

N3b - Macroscopic nodal metastasis N3c - Satellite(s) or in‐transit metastasis with two or more regional nodal metastasis

Notes: Satellites are tumour nests or nodules (macro‐ or microscopic) within 2 cm of the primary tumour. In‐transit metastasis involves skin or subcutaneous tissue more than 2 cm from the primary tumour but not beyond the regional lymph nodes.

M - distant metastasis

M value Description

M0

No distant metastasis

M1

Distant metastasis*

M1a - Skin, subcutaneous tissue or lymph node(s) beyond the regional lymph nodes

M1b - Lung

M1c - Other non‐central nervous system sites

M1d - Central nervous system

Note: 

* Suffixes for M category: (0) lactic dehydrogenase (LDH) – not elevated (1) LDH – elevated so that M1a(1) is metastasis in skin, subcutaneous tissue, or lymph node(s) beyond the regional lymph nodes with elevated LDH.

No suffix is used if LDH is not recorded or unspecified.


TNM pathological classification

pT - primary tumour

pT value Description

pTX

Primary tumour cannot be assessed*

pT0

No evidence of primary tumour

pTis

Melanoma in situ (Clark level I) (atypical melanocytic hyperplasia, severe melanocytic dysplasia, not an invasive malignant lesion)

pT1

Tumour 1 mm or less in thickness

pT1a – less than 0.8 mm in thickness without ulceration

pT1b – less than 0.8 mm in thickness with ulceration or 0.8 mm or more but no more than 1mm in thickness, with or without ulceration

pT2

Tumour more than 1 mm but not more than 2 mm in thickness

pT2a - without ulceration

pT2b - with ulceration

pT3

Tumour more than 2 mm but not more than 4 mm in thickness

pT3a - without ulceration

pT3b - with ulceration

pT4

Tumour more than 4 mm in thickness

pT4a - without ulceration

pT4b - with ulceration

* pTX includes shave biopsies and regressed melanomas

pN - regional lymph nodes

The pN categories correspond to the N categories

pN value Description

pN0

Histological examination of a regional lymphadenectomy specimen will ordinarily include 6 or more lymph nodes. If the lymph nodes are negative, but the number ordinarily examined is not met, classify as pN0. Classification based solely on sentinel node biopsy without subsequent axillary lymph node dissection is designated (sn) for sentinel node, e.g., (p)N1(sn).


Download

Click on the box below to download a PDF version of this data sheet:

Last edited: 4 July 2023 10:07 am

  1. Cancer staging guidance sheets
  2. Lip and oral cavity (ICD10 C00, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C10-14, C30-32)
  4. Pharynx (ICD10 C01, C05.1-2, C09, C10.0, C10.2-3, C11-13)
  5. Major salivary glands (ICD10 C07, C08)
  6. Oesophagus including oesophagastric junction (ICD10 C15 & C16.0)
  7. Stomach (ICD10 C16 except C16.0)
  8. Small intestine (ICD10 C17)
  9. Appendix (ICD10 C18.1)
  10. Colon and rectum (ICD10 C18-C20)
  11. Anal canal and perianal skin data (ICD10 C21, C44.5)
  12. Liver (ICD10 C22.0)
  13. Intrahepatic bile ducts (ICD10 C22.1)
  14. Gallbladder (ICD10 C23, C24.0)
  15. Distal extrahepatic bile duct (ICD10 C24.0)
  16. Perihilar bile ducts (ICD10 C24.0)
  17. Ampulla of vater (ICD10 C24.1)
  18. Pancreas (ICD10 C25)
  19. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  20. Larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
  21. Lung (ICD10 C34)
  22. Thymic tumours (ICD10 C37)
  23. Soft tissues (ICD10 C38.1-2, C47-C49)
  24. Bone (ICD10 C40 & C41)
  25. Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)
  26. Merkel cell carcinoma of skin (ICD10 C44 & C63.2)
  27. Skin carcinoma of the head and neck (ICD10 C44.0, C44.2-4)
  28. Carcinoma of skin of the eyelid (ICD10 C44.1)
  29. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  30. Pleural mesothelioma (ICD10 C45)
  31. Breast tumours (ICD10 C50)
  32. Vulva (ICD10 C51)
  33. Cervix uteri (ICD10 C53)
  34. Uterine sarcomas
  35. Uterus - endometrium (ICD10 C54.1, C55)
  36. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  37. Gestational trophoblastic neoplasms (ICD10 C58)
  38. Penis tumours (ICD10 C60)
  39. Prostate tumours (ICD10 C61)
  40. Testis tumours (ICD10 C62)
  41. Kidney tumours (ICD10 C64)
  42. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  43. Urinary bladder tumours (ICD10 C67)
  44. Urethra tumours (ICD10 C68.0)
  45. Carcinoma of conjuctiva (ICD10 C69.0)
  46. Malignant melanoma of conjuctiva (ICD10 C69.0)
  47. Retinoblastoma (ICD10 C69.2)
  48. Malignant melanoma of uvea (ICD10 C69.3, C69.4)
  49. Carcinoma of lacrimal gland (ICD10 C69.5)
  50. Sarcoma of orbit (ICD10 C69.6)
  51. Thyroid gland (ICD10 C73)
  52. Adrenal cortex (ICD10 C74.0)
  53. Chronic lymphocytic leukaemia
  54. Hepatoblastoma (CTYA)
  55. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  56. Medulloblastoma
  57. Multiple myeloma
  58. Neuroblastoma
  59. Neuroendocrine tumours of the foregut
  60. Neuroendocrine tumours of the midgut and hindgut
  61. Non-hodgkin lymphoma (children)
  62. Rhabdomyosarcoma and other soft tissue sarcomas (CTYA)
  63. Wilms tumour of the kidney